Venous thromboembolism (VTE) consists of deep vein thrombosis (DVT) and pulmonary embolism (PE) and represents a significant clinical challenge.
3rd Leading

cardiovascular disease is VTE. ¹

300,000 Deaths

in the U.S. are caused by VTEs each year. ²

Up to 50% of patients with DVT

will develop long-term complications, including post-thrombotic syndrome (PTS). ³

Current thrombolysis (pharmacological) & thrombectomy (mechanical) solutions have advanced interventional therapy, but still fall short of providing optimal outcomes.
Interventional treatment of VTE is due for disruption.
SonoThrombectomy™
‍Next Generation, Total Clot Solution
Interventional treatment of VTE is due for disruption.

Triple Action Clot Debulking Catheter System

driven by microbubble-mediated cavitation

Single Session

cath lab based interventional procedure

Designed to be Safer, More Effective, & Less Expensive

with no ICU treatment required

SonoThrombectomy™
‍Next Generation, Total Clot Solution

Triple Action Clot Debulking Catheter System

driven by microbubble-mediated cavitation

Single Session

cath lab based interventional procedure

Designed to be Safer, More Effective, & Less Expensive

with no ICU treatment required

110+ Years of MedTech Experience
Daniel Estay
Founder + CEO
FULL BIO
Luke Harada
Chief Operating Officer
FULL BIO
Jacob Ruprecht
VP of Engineering
FULL BIO
Craig Nichols
VP of Clinical & RA/QA
FULL BIO
Mohamed Lahlou
Principal Engineer, Ultrasound Hardware
FULL BIO
John Ranshaw
Senior Engineer, Mechanical Systems
FULL BIO
Hannah Florez
Engineer,
Catheters & Accessories
FULL BIO
Michael Romero
Principal Engineering Technician
FULL BIO
Board of Directors
Daniel Estay
Founder & CEO, SonoVascular, Inc.
‍
Bill Starling
Co-Founder and CEO, Synecor, LLC
Scientific Advisory Board
Kush Desai, MD, FSIR
Director, Deep Venous Interventions
Northwestern Memorial
Associate Professor of Radiology, Surgery & Medicine
Northwestern University Feinberg School of Medicine   
Lawrence Garcia, MD, FACC
Systems Chief, Vascular Services
Catholic Health Services
St. Francis Hospital & Heart Center
William Gray, MD, FACC
System Chief, Division of Cardiovascular Diseases
Main Line Health
Professor, Lankenau Institute for Medical Research
Andrew Holden, MD
Director of Interventional Radiology
Auckland City Hospital
Professor of Radiology, University of Auckland
Robert Lookstein, MD, FSIR
Executive Vice Chairman, Dept. of Diagnostic, Molecular, and
Interventional Radiology
Mount Sinai Health System
Professor of Radiology & Surgery
Ichan School of Medicine Mount Sinai
William Marston, MD, FACS
Medical Director, Wound Management Center,
Division of Vascular Surgery
UNC Health
Professor of Surgery,
University of North Carolina at Chapel Hill School of Medicine  
Kenneth Rosenfield, MD, FACC
Section Head, Vascular Medicine and Intervention
Massachusetts General Hospital
Founder, Pulmonary Embolism Response Team (PERT) Consortium
VIEW THE BOARD
Press
SonoVascular Announces
Successful Treatment of First
Patient with its
SonoThrombectomyTM System
READ MORE
SonoVascular Enters into Strategic Collaboration with Lantheus Holdings, Inc. for Use of Microbubbles in Combination with SonoThrombectomy System for Treatment of Venous Thromboembolism
READ MORE
Novel Microbubble-Enhanced Ultrasound Procedure Shows Promise in Acute Porcine DVT Model Test
READ MORE
WIN Backs SonoVascular Ahead of Clinical Trials
READ MORE
Standout Strategies for Next-Gen Venous Devices
READ MORE
Clot-Busting Combination
READ MORE
Chapel Hill Entrepreneur aims for $10M+ Raise to Support Clinical Studies
READ MORE
SonoVascular's SonoThrombectomy System is not FDA cleared and is limited by Federal laws to investigational use only.
‍
Let's Connect
Looking to invest or join us while we transform the treatment of Venous Thromboembolism?
Reach out, and let's talk.
Contact Us
Email
info@sonovascular.com
Address
101 Glen Lennox Drive, Suite 250
Chapel Hill, NC 27517
© 2024 SonoVascular, Inc. All rights reserved

References:
1. Gregson J, Kaptoge S, Bolton T, et al. Cardiovascular Risk Factors Associated With Venous Thromboembolism. JAMA Cardiol. 2019;4(2):163–173. doi:10.1001/jamacardio.2018.4537.
2. Wendelboe AM, Campbell J, McCumber M; Bratzler D; Ding K, Beckman M, Reyes N; Raskob G. The Design and Implementation of a New Surveillance System for Venous Thromboembolism using Combined Active and Passive Methods. American Heart Journal. 2015.
3. Centers for Disease Control and Prevention. Data and Statistics on Venous Thromboembolism 2022.